Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | Video Game Development | Contact

Biotechnology Animations – Biotechnology Illustrations

Clinical Animations / Trial Animations

Clinical Studies Animated Method of Action Video

Medical Animation Studio produces clinical animations and clinical illustrations.  Custom 3d trail illustrations and clinical illustrations for e learning can also be produced.   Biotechnology animations and biotechnology illustrations created for biotech companies and biotechnology marketing companies.
Biotechnology animated method of action video. 
Dr Nano
Pluristem reports data showing PLX-PAD cells effective in treating Duchenne muscular dystrophy
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, has reported positive data from preclinical studies of its PLX-PAD cells in the treatment of Duchenne...
Brain training video games in ground-breaking clinical trial to tackle cognitive impairment in people with Parkinson's
MyCognition, a leading cognitive assessment and training company, has announced it is launching a ground-breaking clinical trial, addressing the cognitive impact of Parkinson's disease, led by...
Multi-centre trial to test new treatment for chronic cough
A clinical trial to test a promising new treatment for chronic cough that could lead to the first new cough drug in 50 years has been launched by the National Institute for Health Research.
Diabetes: Faster-acting insulin aspart vs NovoRapid results
Full results from onset 1 and onset 2 - the phase 3a trials assessing the use of faster-acting insulin aspart in people with type 1 diabetes (onset 1) and type 2 diabetes (onset 2) - were presented...
Erenumab significantly reduces patients' monthly migraine days in Phase 2 study for the prevention of chronic migraine
Amgen has announced positive top-line results from the global Phase 2 study evaluating the efficacy and safety of erenumab (AMG 334) in chronic migraine prevention.
Investigational immunotherapy drug well tolerated in those with rare form of melanoma
An investigational immunotherapy drug being tested in the treatment of a rare form of skin cancer known as Merkel cell carcinoma has been found to be well tolerated with a clinical benefit seen in...
Pembrolizumab elicits significant antitumor activity in head and neck cancer patients
Treating head and neck cancer patients with recurrent or metastatic disease with the PD-1 inhibitor pembrolizumab resulted in significant clinical responses in a fifth of the patients from a phase...
Lenalidomide maintenance therapy improves overall survival for patients with multiple myeloma
While several clinical trials have demonstrated that maintenance therapy with lenalidomide reduces the risk of disease progression in patients with multiple myeloma, there have been no definitive...
Data shows around a third of advanced kidney cancer patients still alive at five years with Opdivo (nivolumab)
Bristol-Myers Squibb has announced the latest long-term overall survival (OS) results from two dose-ranging Phase I and Phase II studies, CA209-003 and CA209-010, which evaluated nivolumab in...
Recurrent C. diff infection reduced for high-risk patients in new trials
An analysis presented at Digestive Diseases Week in San Diego, CA, shows bezlotoxumab reduces rates of recurrent C. diff infection in high-risk patients.
Does using biomarker to select patients for Phase 1 trials improve efficacy?
Precision or personalized medicine is about selecting patients with a particular protein or genomic biomarker who might benefit from a specific therapy.
Immunotherapy combination of nivolumab and ipilimumab shows promising tumour reduction in lung cancer
Bristol-Myers Squibb has announced updated results from the CheckMate -012 study, a multi-arm, Phase Ib trial evaluating nivolumab alone or in combination with other therapies, in patients with...
New drug 'retrains' immune system to fight aggressive bladder cancer
A new drug that harnesses the immune system to attack tumors is highly effective against advanced bladder cancer, according to the results of an international clinical trial presented at the annual...
Atopic dermatitis: Positive topline Phase 3 results announced for dupilumab
Regeneron Pharmaceuticals, Inc. and Sanofi have announced that a one-year Phase 3 study, known as LIBERTY AD CHRONOS, evaluating investigational dupilumab met its primary and key secondary...
Real world study shows ivabradine significantly improved quality of life in elderly patients with heart failure
Older heart failure patients, prescribed Procoralan® (ivabradine), have been shown to experience a significant improvement in quality of life (QoL); a key priority in the treatment of heart...
WindowsFlashQuicktime
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2016
Content Management / Website Design by Tresware